SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: orkrious who wrote (6143)4/11/2002 8:28:05 PM
From: tom pope  Read Replies (2) | Respond to of 52153
 
7% convertible subordinated debentures, due 2005 $ 299,960
5% convertible subordinated debentures, due 2007 $ 460,000
5.75% convertible subordinated notes, due 2006 $500,000

I think that's it. all #'s in 000's



To: orkrious who wrote (6143)4/11/2002 9:53:28 PM
From: LLCF  Respond to of 52153
 
Good question... but if I remember correctly it was a convert that came out not that long ago.

DAK



To: orkrious who wrote (6143)4/15/2002 8:47:04 AM
From: RMP  Read Replies (2) | Respond to of 52153
 
Human Genome Q1 shr loss $0.30. The EPS estimate was at loss $0.32. The miss by .02 seems to have caused an over reaction in pre market trading. I would like to know how others view this. The conference call at 1pm may provide some support.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News